The global excipients market is anticipated to reach USD 5.22 billion by 2020, growing at a CAGR of 6.0% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing developments in the field of medicine formulation and rise in research in the field of dosage technology are expected to drive this industry through the forecast period.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/excipients-market-analysis
Further key findings from the study
suggest:
·
Introduction of novel technologies for
utilization of generic drugs in the development of new formulations is expected
to boost growth of this industry over the forecast period. Furthermore,
increasing global geriatric population base is anticipated to significantly
raise demand for pharmaceuticals as this segment of the population is prone to
high risk of organ disorders and infections, thereby propelling market
growth.
·
Increasing demand for diverse excipients
pertaining to interaction with active pharmaceutical ingredients and ongoing R&D
for developing sustained and immediate drug delivery techniques for novel drugs
is also expected to serve as high impact driver for the growth of this industry
over the forecast period.
·
Polymer segment dominated with respect to market
share in 2014 with over 45% of global excipients revenue. Factors contributing
towards high revenue share of this segment in 2014 include growing demand for
major polymers such as lubricants, anti-adherents, fillers/diluents, binders,
disintegrants, and coating materials in the pharmaceutical and cosmetic
industries.
·
Sugar segment is expected to register fast
growth of about 7.0% over the forecast period owing to higher consumption rate
of sugar in different drug formulations. Benefits associated with use of sugars
as sweetening agents and disintegrants such as longer disintegration times,
odorless formulations even on long storage, inert nature, and low expenses are
expected to fuel growth of this segment through to 2022.
·
Europe was observed to be the dominant region
for excipients industry accounting for 32% of global revenue in 2014 owing to
the presence of a large number of pharmaceutical manufacturers, high demand for
medicine products as a consequence of rising geriatric population base in the
western European countries.
·
Asia Pacific region is expected to grow at
lucrative rate and its revenue is estimated to reach over USD 1,500 million in
2020. Presence of low cost manufacturing options and high unmet medical needs
in countries of this region are factors that are anticipated to attribute to
growth of this industry in the given region through to 2020.
·
Major players in this industry include P&G,
Avantor Performance Materials, Inc., Huntsman Corporation, BASF, Eastman
Chemical Company, Danisco A/S, Ashland Inc., Roquette, Colorcon, Inc., FMC
Corporation, Evonik Industries, and Lubrizol Corporation. This industry is
competitive in nature marked by high industry rivalry levels. Players are
striving to gain competitive advantage by focusing on stringent regulations
issued by regulatory bodies pertaining to safety of finished products.
Browse All Reports of
this category @ http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the global excipients market on the basis of product and region:
Excipients Product Outlook
• Polymers
• MCC (Microcrystalline Cellulose)
• HPMC (Hydroxypropyl Methyl Cellulose)
• Ethyl Cellulose
• Methyl Cellulose
• CMC (Carboxymethyl Cellulose)
• Croscarmellose Sodium
• Povidone
• Pregelatinized Starch
• Sodium Starch Glycolate
• Polyethylene Glycol
• Acrylic Polymers
• Minerals
• Calcium Phosphate
• Calcium Carbonate
• Clay
• Silicon Dioxide
• Titanium Dioxide
• Others
• Sugars and Others
• Lactose
• Sucrose
• Others
• Alcohol
• Glycerin
• Propylene Glycol
• Sorbitol
• Mannitol
• Others
• Gelatin
Excipients Regional Outlook
• North America
• Europe
• Asia Pacific
• RoW
No comments:
Post a Comment